Abbott Laboratories (ABT)
NYSE: ABT · IEX Real-Time Price · USD
105.27
-0.63 (-0.59%)
At close: Apr 18, 2024, 4:00 PM
105.04
-0.23 (-0.22%)
After-hours: Apr 18, 2024, 4:10 PM EDT
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of $182.66 billion as of April 18, 2024. Its market cap has increased by 1.75% in one year.
Market Cap
182.66B
Enterprise Value
190.11B
1-Year Change
1.75%
Ranking
Category
Stock Price
$105.27
Market Cap Chart
Since December 1, 1998, Abbott Laboratories's market cap has increased from $72.66B to $182.66B, an increase of 151.38%. That is a compound annual growth rate of 3.70%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2024 | 183.76B | -3.03% |
Apr 16, 2024 | 189.50B | 0.29% |
Apr 15, 2024 | 188.94B | -0.20% |
Apr 12, 2024 | 189.33B | -2.10% |
Apr 11, 2024 | 193.39B | 0.25% |
Apr 10, 2024 | 192.90B | -1.13% |
Apr 9, 2024 | 195.10B | 1.74% |
Apr 8, 2024 | 191.77B | -0.61% |
Apr 5, 2024 | 192.95B | 0.99% |
Apr 4, 2024 | 191.06B | -1.05% |
Apr 3, 2024 | 193.09B | -0.66% |
Apr 2, 2024 | 194.38B | -0.06% |
Apr 1, 2024 | 194.50B | -1.38% |
Mar 28, 2024 | 197.22B | 0.16% |
Mar 27, 2024 | 196.91B | 1.78% |
Mar 26, 2024 | 193.47B | 1.35% |
Mar 25, 2024 | 190.89B | -0.51% |
Mar 22, 2024 | 191.86B | -0.84% |
Mar 21, 2024 | 193.49B | 0.01% |
Mar 20, 2024 | 193.47B | -1.47% |
Mar 19, 2024 | 196.35B | 0.64% |
Mar 18, 2024 | 195.10B | -2.64% |
Mar 15, 2024 | 200.40B | -2.83% |
Mar 14, 2024 | 206.23B | -1.09% |
Mar 13, 2024 | 208.50B | -0.50% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Johnson & Johnson | 347.06B |
Merck & Co. | 316.93B |
AbbVie | 289.93B |
AstraZeneca | 212.37B |
Thermo Fisher | 208.68B |
Novartis AG | 181.74B |
Danaher | 177.11B |
Pfizer | 143.48B |